Colorectal Cancer Clinical Trials in Pennsylvania

Showing 181-200 of 282 trials

Sample Collection Study for the CellMax Life Circulating Tumor Cell and Circulating Tumor DNA Platforms for the Early Detection of Colorectal Cancer and Adenomas

NCT05127096

The purpose of this study is to collect clinical specimens from subjects with a diagnosis of colorectal cancer/advanced adenoma or undergoing a screening colonoscopy and meeting study eligibility criteria.

Colorectal Cancer Screening

CellMax Life1,000 participantsStarted Dec 2020

Huntsville, Alabama, United States • Chula Vista, California, United States • Lancaster, California, United States +12 more locations

COMPLETEDNA36 miles

Hybrid APC Assisted EMR for Large Colon Polyps

NCT03390907

The purpose of this study to evaluate and examine whether use of Hybrid Argon Plasma Coagulation (APC) as an adjunct to endoscopic mucosal resection (EMR) will reduce the risk of residual or recurrent neoplasia at 6 months. Hybrid APC is an existing FDA approved device used to assist with ablation of abnormal tissue anywhere in the GI tract.

Colon PolypColon AdenomaColon Cancer

Milton S. Hershey Medical Center40 participantsStarted Sep 2018

Hershey, Pennsylvania, United States

UNKNOWN40 miles

Longitudinal Performance of Epi proColon

NCT03218423

This study will evaluate longitudinal performance of Epi proColon with respect to test positivity, longitudinal adherence to Epi proColon screening, adherence to follow-up colonoscopy and diagnostic yield, as well as assay failure rates.

Colorectal CancerColorectal Neoplasms

Epigenomics, Inc4,500 participantsStarted Aug 2017

San Diego, California, United States • Royal Oak, Michigan, United States • New Brunswick, New Jersey, United States +3 more locations

Sample Collection Study for the CellMax Life Circulating Tumor Cell and Circulating Tumor DNA Platforms for the Early Detection of Colorectal Cancer and Adenomas

Hybrid APC Assisted EMR for Large Colon Polyps

Longitudinal Performance of Epi proColon

Colorectal Cancer Trials in Other Cities

NSABP Patient Registry and Biospecimen Profiling Repository

Safety and Efficacy Study of Neratinib and Cetuximab to Treat Patients With Quadruple Wild-Type Metastatic Colorectal Cancer

A Study of PDR001 in Combination With CJM112, EGF816, Ilaris® (Canakinumab) or Mekinist® (Trametinib)

Study to Explore the Safety, Tolerability and Efficacy of MK-3475 in Combination With INCB024360 in Participants With Selected Cancers

The National CT Colonography Trial

Phase 2a Study of BAX69 and 5-FU/Leucovorin or Panitumumab Versus Standard of Care in Subjects With Metastatic Colorectal Cancer

5-Fluorouracil, Bevacizumab, and Radiation Followed by Modified FOLFOX6 and Bevacizumab in Stage II/III Rectal Cancer

Bevacizumab and Cetuximab in Combination With FOLFOX6 in Patients With Metastatic Colorectal Cancer

Plasma-based Colorectal Cancer Screening Research & Development

Safety Study of 90Y-hMN14 to Treat Colorectal Cancer

Comparison of Adenoma Detection Rate With ENDOCUFF VISION® vs. G-EYE®

Regorafenib+FOLFIRI Versus Placebo+FOLFIRI as 2nd Line Tx in Metastatic Colorectal Cancer

MGD007 Combined With MGA012 in Relapsed/Refractory Metastatic Colorectal Cancer

Study of Safety and Efficacy of Ribociclib and Trametinib in Patients With Metastatic or Advanced Solid Tumors

Phase I/Ib Study of NIS793 in Combination With PDR001 in Patients With Advanced Malignancies.

EL CENTRO: Engaging Latinos in the Center of Cancer Treatment Options

A Study to Evaluate the Safety, Tolerability, and Activity of TAK-931 in Participants With Metastatic Pancreatic Cancer, Metastatic Colorectal Cancer, and Other Advanced Solid Tumors

Other Conditions in Pennsylvania